Related Experiment Video

Updated: May 14, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.4K

Dual roles of methylglyoxal in cancer

Zongao Wang1, Shaojun Liu1, Minghui Zhang1

  • 1Department of Oncology, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.

Frontiers in Oncology
|May 12, 2025
PubMed

Insights

Methylglyoxal (MG) exhibits dual roles in cancer, acting as both pro-tumor and anti-tumorigenic. New therapies targeting MG metabolism could lead to precise, individualized cancer treatments.

Area of Science:

  • Oncology
  • Metabolic pathways
  • Cancer biology

Background:

  • Current cancer treatments like chemotherapy, targeted therapy, and immunotherapy face challenges due to drug resistance.
  • Methylglyoxal (MG), a metabolite, displays hormetic properties, influencing cancer progression through concentration-dependent pro- or anti-tumor effects.
  • Understanding MG's role in cancer metabolism is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the dual role of methylglyoxal (MG) in cancer progression and its impact on cellular metabolism.
  • To explore the potential of targeting MG-related metabolic pathways for cancer treatment.
  • To propose novel therapeutic strategies based on MG's concentration-dependent effects.

Main Methods:

  • Review and analysis of existing literature on methylglyoxal (MG) metabolism in cancer.
  • Investigation of MG's effects on cell metabolism and tumor progression at different concentrations.
  • Conceptualization of MG-based therapeutic approaches.

Main Results:

  • Methylglyoxal (MG) exhibits a dual role in cancer, with concentration-dependent pro-tumor and anti-tumorigenic actions.
  • MG influences key cellular metabolic pathways relevant to cancer progression.
  • Targeting MG metabolism presents a promising avenue for novel anti-cancer drug development.

Conclusions:

  • MG's hormetic nature offers unique opportunities for developing precise cancer therapies.
  • MG capture therapy is proposed for pre-cancerous stages, while MG toxicity therapy is suggested for the cancer stage.
  • These MG-targeted strategies could contribute to individualized and effective cancer treatment plans.
Keywords:
cancerglyoxalase 1hormesismethylglyoxaltherapeutics

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.4K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

594

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K